Manijeh Berenji, MD, MPH

The Board advises the Secretary on certain technical aspects of the EEOICPA, including: the Department's site exposure matrices database, which includes information about toxic substances present at EEOICPA-covered facilities, and established causal links between those substances and certain occupational illnesses. EEOICPA provides compensation and medical benefits to nuclear weapons workers diagnosed with medical conditions caused by their exposure to toxic substances at covered nuclear facilities. Executive Order 13699 directed the Department to establish the Advisory Board in 2015.

The Board also provides advice on medical guidance for claims examiners under the Energy program, with respect to the weighing of medical evidence provided by claimants; evidentiary requirements for claims under subtitle B related to lung disease; and the work of industrial hygienists, staff physicians and consulting physicians, and their reports, to ensure quality, objectivity, and consistency.

Media Contact:

Please reach out to the Boston Medical Center Media Relations team with any questions.

 

Return to BMC News